Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 3

Clinical implications of fungal isolation from sputum in adult patients with cystic fibrosis

Pages
1191–1200
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Frequent use of parenteral antibiotics and use of nutritional supplementation were found to be independent risk factors for fungal isolation from sputum in adult CF.Key words: Adult cystic fibrosis, sputum, fungi

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Cystic fibrosis is an autosomal recessive disease with a defect in mucociliary activity that is characterized by recurrent pulmonary infections.
📊
Key Findings & Data:Materials and methods: This retrospective study included patients who have been admitted between October 2017 and January 2019 in an adult cystic fibrosis unit.
💡
Conclusion & Impact:Conclusion: Frequent use of parenteral antibiotics and use of nutritional supplementation were found to be independent risk factors for fungal isolation from sputum in adult CF.Key words: Adult cystic fibrosis, sputum, fungi
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Background/aim: Cystic fibrosis is an autosomal recessive disease with a defect in mucociliary activity that is characterized by recurrent pulmonary infections. Bacterial agents frequently implicated in airway colonization are Haemophilus influenzae, Staphylococcus spp., and Pseudomonas spp. Fungal isolation from sputum is common in adults. However, growth of fungal agent only in sputum culture in patients with cystic fibrosis is insufficient for the diagnosis of fungal diseases. There is limited data about the clinical significance of fungal isolation in sputum cultures. The aim of the study was to investigate the clinical outcomes andsignificance of fungal isolation from sputum samples in adult CF. Materials and methods: This retrospective study included patients who have been admitted between October 2017 and January 2019 in an adult cystic fibrosis unit. Patients were grouped according to fungal pathogenicity as; fungal disease group, colonization group, and nonisolated group. The data of the last one year, including demographics, clinical data, laboratory, treatment modalities, results of cultured bacteria and fungus from sputum samples, respiratory function parameters, frequency of exacerbation, and hospitalizationwere compared between groups. Results: A total of 330 sputum samples from 88 adult patients with CF were collected. Patients were divided into 3 groups, the fungal disease group (n = 10, 11.4%), colonization group (n = 49, 55.7%), and nonisolated group (n = 29, 32.9%). Presence of pulmonary exacerbation, number of admissions to emergency department, and the number of positive cultures for bacteria from sputum were higher in the fungal disease group (p = 0.03, p = 0.01 and p < 0.001). The fungal disease group had higher rate of antibiotics by parenteral routethan other groups (p = 0.001) whereas lung functions were similar. Use of nutritional supplementation and parenteral antibiotherapy were the factors associated with elevated risk of fungal isolation. Conclusion: Frequent use of parenteral antibiotics and use of nutritional supplementation were found to be independent risk factors for fungal isolation from sputum in adult CF.Key words: Adult cystic fibrosis, sputum, fungi

🔖

Cite This Article

ERSÖZ, D. D., AKDAĞLI, S. A., İNKAYA, A. Ç., ER, B., ÖZÇELİK, H. U., KİPER, E. N., KALYONCU, A. F., IRMAK, İ., SIĞ, A. K., GÜLMEZ, D., GÜVEN, D. K., DAMADOĞLU, E., TURAL, D. A., HÜSEYNOVA, X. (2022). Clinical implications of fungal isolation from sputum in adult patients with cystic fibrosis. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 3, 1191–1200. https://ajindex.com/articles/609463

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Boyle MP, Bell SC, Konstan MW, McColley SA, Rowe SM et al. A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial. Lancet Respiratory Medicine 2014
  2. doi: 10.1016/ S2213-2600(14)70132-8 2. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell S et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. New England Journal of Medicine 2011
  3. doi: 10.1056/NEJMoa1105185 3. Middleton PG, Chen SC, Meyer W.Fungal infections and treatment in cystic fibrosis. Current Opinion in Pulmonary Medicine 2013
  4. 19 (6): 670-675. doi: 10.1097/MCP.0b013e328365ab74 4. Muthig M, Hebestreit A, Ziegler U, Seidler M, Müller FM. Persistence of Candida species in the respiratory tract of cystic fibrosis patients. Medical Mycology 2010
  5. doi: 10.3109/13693780802716532 5. Noni M, Katelari A, Kaditis A, Theochari I, Lympari I et al. Candida albicans chronic colonisation in cystic fibrosis may be associated with inhaled antibiotics. Mycoses 2015
  6. doi: 10.1111/myc.12338 6. Saunders R, Modha D, Claydon A, Gaillard E. Chronic Aspergillus fumigatus colonisation of the cystic fibrosis airway is common and may be associated with a more rapid decline in lung function. Journal of Cystic Fibrosis 2011
  7. 10 (1): S37. doi: 10.1016/S1569-1993(11)60162-8 7. Milla CE, Wielinski CL, Regelmann WE. Clinical significance of the recovery ofAspergillus species from the respiratory secretions of cystic fibrosis patients.Pediatric Pulmonology 1996
  8. 21 (1): 6-10. doi: 10.1002/(SICI)1099-0496(199601)21:1 3.0.CO
  9. R 8. Bakare N, Rickerts V, Bargon J, Just-Nübling G. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003
  10. 46 (1-2): 19- 23. doi: 10.1046/j.1439-0507.2003.00830.x 9. Valenza G, Tappe D, Turnwald D, Frosch M, König C et al. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. Journal of Cystic Fibrosis 2008
  11. 7 (2): 123-127. doi: 10.1016/j. jcf.2007.06.006. 10. Bargon J, Dauletbaev N, Köhler B,Wolf M, Posselt HG et al. Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus spp. colonization in adult cystic fibrosis patients. Respiratory Medicine 1999
  12. 93 (11):835-838.doi: 10.1016/S0954-6111(99)90270-6 11. Maturu VN, Agarwal R. Prevale